Amgen Inc. (NASDAQ:AMGN) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. In 2023, the company finalized its $28 billion acquisition of Horizon Therapeutics, a smaller biotech firm.

The S&P 500 and Nasdaq Composite ended little changed on Friday, overcoming a brief dip triggered by a Financial Times report indicating U.S. President Donald Trump was pushing for steep new tariffs on European Union products.

Stocks turned in a lackluster performance Friday as Wall Street took a breather at the end of the first week of earnings-reporting season.

Key Points The Nasdaq-100 Index performed very well in the month of June.The two top performers saw their prices increase nearly 5 times the index.Micron Technology and Arm Holdings were major winners for their shareholders.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Petco (NASDAQ:WOOF) and the best and worst performers in the specialty retail industry.

Nvidia took a $4.5 billion write-off in its latest quarter on unsold H20 chips that it was unable to repurpose for other markets. If sales of these high-volume chips to China resume, a reversal of this write-off could boost earnings.

Three magnificent businesses with well-defined catalysts can deliver triple-digit returns amid a historically pricey stock market.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Amgen (NASDAQ:AMGN) and the rest of the therapeutics stocks fared in Q1.